Key challenges in formulating Emamectin Benzoate
- Achieving uniform particle size distribution
- Maintaining long‑term suspension stability
- Preventing viscosity increase during storage
These issues become more pronounced in combination formulations, where interactions between multiple active ingredients may cause excessive viscosity build-up, gelling, or instability after accelerated heat testing or prolonged warehouse storage. Additionally, the crystalline nature of Emamectin Benzoate can lead to difficulties during milling, further complicating the production process.
Solutions to overcome Emamectin Benzoate formulation challenges
To overcome these challenges, selecting appropriate surfactants is essential. Azelis recommends Geropon® K30D or a combination of Antarox® B848 with Supragil® MNS 90, to address the specific formulations needs. Keen to find out more?
Would you like to know more?
Please sign in or request access to get access to the full content. In case you have any questions, please click the "Request information" button below.